BioSpace News Archive

Akoya Biosciences, Inc., The Spatial Biology Company®, announced the pricing of its initial public offering of 6,580,000 shares of its common stock at a price of $20.00 per share, for gross proceeds of $131.6 million, before underwriting discounts and commissions and offering expenses payable by Akoya.

Development of new-generation drug-eluting balloon catheters has been gaining pace, thanks to increasing research and development initiatives

A wide range of tests finds clinical application in blood group typing—there are as many as 33 blood group systems. Quite wide array of techniques and instruments have become popular in cross-matching tests in transfusion medicine.

Being a rich source of bioactive compounds, including peptides and proteins, fish have instigated immense interest among pharmaceutical and nutraceutical manufacturers.

The global CBD hemp oil market is expanding owing to with increasing prevalence of chronic and infectious diseases across the globe.

Increasing demand for localized cancer diagnostics is driving research into blood-based sample applications, owing to ease of use.

Transparency Market Research has published a new report titled, ‘Antibacterial Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.

The prudent efforts of the medical research fraternity to eliminate bacterial infections has created ripples across the global meningococcal vaccines market.

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, would like to announce that, further to its press release of April 12, 2021, its Annual and Special Meeting (the “Meeting”) has been rescheduled to take place on Monday April 19, 2021 at 11:00 a.m. E.D.T

DignifiHealth, a company that has integrated leading digital health technologies with its proprietary big-data intelligence platform, has raised $7 million in seed funding to scale delivery of its revolutionary suite of healthcare products on a national scale.